A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Eli Lilly and Company
Merck Sharp & Dohme LLC
Imunon
CanariaBio Inc.
Genelux Corporation
Merck Sharp & Dohme LLC
Genmab
AbbVie
Merck Sharp & Dohme LLC
Mural Oncology, Inc
AbbVie
pharmaand GmbH
Corcept Therapeutics
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Hoffmann-La Roche
ImmunoGen, Inc.
pharmaand GmbH
Advenchen Laboratories, LLC
Mersana Therapeutics
pharmaand GmbH
pharmaand GmbH
Pfizer
Hoffmann-La Roche
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
OncXerna Theraputics, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Sotio Biotech Inc.
Novartis
Novartis
ImmunoGen, Inc.
Janssen Research & Development, LLC
Amgen
Genentech, Inc.
Amgen
Amgen
MEI Pharma, Inc.
INSYS Therapeutics Inc
Oasmia Pharmaceutical AB
Eli Lilly and Company
Eli Lilly and Company